secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001213900-25-120067
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio terminates $75M ATM sales agreement with RBC and BTIG effective Dec 19, 2025
--------------------------------------------------------------------------------

- Company notified RBC and BTIG of termination on Dec 5 and Dec 9, 2025; effective Dec 19.
- No termination penalties or expenses incurred.
- Prior to termination, co. raised ~$10.5M net proceeds through sale of 1,353,469 shares.
- Original agreement allowed up to $75M in at-the-market offerings since Aug 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025120067/0001213900-25-120067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025120067/ea0269071-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-120067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer